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Among the factors influencing the outcome of complex injuries to the extremities, the severity of the associated soft-tissue trauma is still one of the most decisive prog-
nostic determinants. Due to the alarming frequency of high-ve-
locity/high-energy traffic  victims, the prevalence of severe soft-
tissue trauma still continues to increase. Extensive trauma leads 
to activation of the coagulation cascade and is often compli-
cated by systemic inflammation and infection leading to mul-
tiple organ dysfunction syndrome (MODS). Sepsis-induced 
MODS represents the leading cause of death in postoperative 
and post-traumatic ICUs (1). Modulation of the coagulatory 
response following trauma and sepsis allows one to affect key 
features of the pathogenesis of septic shock (2, 3). Antithrom-
bin III, a plasma-derived serine protease inhibitor, controls the 
activity of thrombin and other proteases of the coagulation cas-
cade (4, 5). Furthermore, antithrombin has previously shown 
a large number of anti-inflammatory actions, independent of 
its anticoagulatory effects (6–8). It is supposed that antithrom-
bin interacts with endothelial cells, thus inhibiting leukocyte-
endothelial cell interaction. On the other hand, a direct action 
of antithrombin on leukocyte activation with inhibition of the 
release of proinflammatory mediators is discussed (5).
To date, however, it has not been investigated whether ad-
ministration of antithrombin is indeed of therapeutic ben-
efit for traumatized soft tissue. Thus, the aim of our study 
Background: Closed soft-tissue trauma leads to activation of the 
coagulation cascade and is often complicated by systemic inflam-
mation and infection. Previous investigations have shown potent 
anti-inflammatory properties of antithrombin. We herein report on 
the action of antithrombin on skeletal muscle injury in experimental 
endotoxemia.
Materials and Methods: By using a pneumatically driven computer-
controlled impact device, closed soft-tissue trauma was applied on 
the left hind limb of pentobarbital-anesthetized rats. Six hours later, 
endotoxemia was induced by intraperitoneal injection of Esche-
richia coli lipopolysaccharide. An equivalent volume of physiological 
saline was given in controls. At the same time point, treatment of 
animals was started by intravenous injection of antithrombin (250 
IU/kg body weight) or vehicle solution. Twenty-four hours after 
trauma, the extensor digitorum longus muscle was microsurgically 
exposed and analyzed by means of high-resolution multifluorescence 
microscopy.
Results: Traumatic soft-tissue injury with additional endotoxemia 
was characterized by nutritive perfusion failure (functional capil-
lary density: 379 ± 20 cm/cm²), tissue hypoxia (nicotinamide ade-
nine dinucleotide autofluorescence: 77 ± 4 aU), and enhanced 
leukocyte-endothelial cell interaction (773 ± 35 cells/mm²). Thera-
peutic intervention with antithrombin 6 hrs after trauma restored 
nutritive perfusion and tissue oxygenation (functional capillary 
density: 469 ± 22 cm/cm²; nicotinamide adenine dinucleotide 
autofluorescence: 61 ± 5 aU [p < 0.05]) and reduced inflamma-
tory leukocyte adherence (237 ± 20 cells/mm² [p < 0.05]) toward 
values found in nontraumatized controls (functional capillary den-
sity: 573 ± 13 cm/cm²; nicotinamide adenine dinucleotide autoflu-
orescence: 56 ± 2 aU; leukocyte adherence: 204 ± 20 cells/mm²).
Conclusion: Antithrombin ameliorates microcirculatory dysfunc-
tion and tissue injury in traumatized animals during endotoxemia. 
Furthermore, a reduced inflammatory cell response helps to pre-
vent leukocyte-dependent secondary tissue injury. (Crit Care Med 
2013; 41:867–873)
Key Words: antithrombin; endotoxemia; lipopolysaccharide; 
microcirculation; nicotinamide adenine dinucleotide fluorescence; 
trauma.
Antithrombin Reduces Inflammation and 
Microcirculatory Perfusion Failure in Closed  
Soft-Tissue Injury and Endotoxemia
Philip Gierer, MD1; Fabian Laue, MD1,2; Johannes N. Hoffmann, MD3; Robert Rotter, MD1;  
Thomas Mittlmeier, MD1; Georg Gradl, MD1; Brigitte Vollmar, MD2
 1 Department of Trauma & Reconstructive Surgery, University of Rostock, 
Rostock, Germany.
 2 Institute for Experimental Surgery, University of Rostock, Rostock, Ger-
many.
 3 Department of Surgery, Klinikum Großhadern, Ludwig-Maximilians- 
University, Munich, Germany.
The authors have not disclosed any potential conflicts of interest.
















868 www.ccmjournal.org March 2013 • Volume 41 • Number 3
was to assess the effects of antithrombin on microvascular 
nutritive perfusion and local inflammatory cell response in 




The experimental protocol was approved by the local animal 
rights protection authorities and followed the National Insti-
tutes of Health guidelines for the care and use of laboratory 
animals. A total of 35 male Sprague-Dawley rats (body weight 
[bw]: 250–300 g) were anesthetized with 6% pentobarbital 
sodium (55 mg/kg bw IP; Narcoren; Merial, Hallbergmoos, 
Germany). By means of a pneumatically driven and computer-
controlled impact device, a standardized soft-tissue trauma 
was induced in 28 animals on the lateral compartment of the 
left hind limb, simulating high-velocity trauma of the lower 
extremity (9). The controlled-impact technique was initially 
developed as a model of experimental traumatic brain injury 
in rats, reproducing the pathophysiologic and morphologic re-
sponses of severe closed head injury as found in humans (10, 
11). The controlled-impact device consists of a compressed 
nitrogen gas source, an adjustable impactor, a displacement 
transducer, and a personal computer-assisted interface for 
data transmission and analysis of time/displacement param-
eter of the impact. The impact parameters were selected to 
an impact velocity of 7 m/s, a deformation depth of 11 mm, 
and an impact duration of 100 msec with an impactor diam-
eter of 10 mm. The left hind limb was placed in a plastic mold 
(Technovit; Kulzer, Wertheim, Germany) shaped like the hind 
limb to guarantee optimal energy transmission to the tissue by 
avoiding hind limb movement during the impact.
Six hours after trauma induction, animals underwent a 
second hit by intraperitoneal injection of Escherichia coli li-
popolysaccharide (10 mg/kg bw IP; serotype 128:B12, Sigma, 
Taufkirchen, Germany) (trauma/lipopolysaccharide; n = 7) or 
the equal volume of saline for control (trauma; n = 7). Subse-
quent to lipopolysaccharide or saline exposure, animals were 
treated with antithrombin (250 IU/kg bw [Atenative, Oc-
tapharma, Langenfeld, Germany]; therapy/lipopolysaccharide; n 
= 7 and therapy; n = 7). Following the identical protocol, non-
traumatized animals served as controls (sham; n = 7). Twenty-
four hours after trauma induction, all animals were anesthe-
tized again and placed on a heating pad for maintenance of 
body temperature at 37°C. Following tracheotomy, animals 
were mechanically ventilated (tidal volume: 1 mL/100 g bw; 
50 breaths/min). Catheters (PE-50; Portex, Hythe, Kent, UK) 
were placed in the right carotid artery and left jugular vein for 
continuous monitoring of central hemodynamics (Sirecust; 
Siemens, Germany).
The left extensor digitorum longus (EDL) muscle was micro-
surgically prepared to allow direct access for in vivo high-resolu-
tion multifluorescence microscopy. The preparation technique 
was first described by Tyml and Budreau (12) and modified 
for in vivo microscopy by our group (9). During preparation, 
tissues were superfused with 37°C warm physiological saline 
solution to prevent drying. After final exposure of the EDL 
muscle, tissue was covered with a cover glass.
After baseline recordings (inclusion criteria—mean arterial 
blood pressure: 100–110 mm Hg, hematocrit: 45%–50%, pCo
2
: 
35–40 mm Hg, and pH: 7.35–7.45) and a 20-min stabilization 
period after completion of surgery, in vivo microscopy of the 
EDL muscle was performed. At the end of the experiments, 
animals were killed by exsanguination. Muscle tissue was sam-
pled for subsequent histology and immunohistochemistry.
In Vivo Fluorescence Microscopy. For in vivo analysis of 
the muscle tissue, the surface of the EDL muscle was sequen-
tially scanned from the distal to the proximal part. To reliably 
assess the microcirculation in the muscle, microscopic images 
from ten observation areas in each muscle were recorded (9). 
After intravenous injection of fluorescein isothiocyanate–la-
beled dextran (15 mg/kg bw; Sigma, Deisenhofen, Germany) 
and rhodamine 6G (0.15 mg/kg bw; Sigma), in vivo microsco-
py was performed using a Nikon microscope (E600-FN, Nikon, 
Tokyo, Japan) equipped with a 100 W mercury lamp and filter 
sets for blue (excitation/emission: 465–495 nm or > 505 nm), 
green (510–560 nm or > 575 nm), and ultraviolet (340–380 nm 
or > 400 nm) epi-illumination. By use of water-immersion ob-
jectives (×20/0.75 W and ×40/0.80W, Nikon), final magnifica-
tions of ×306 and ×630 were achieved. Images were recorded 
by means of a charge-coupled device video camera (FK 6990-
IQ-S, Pieper, Schwerte, Germany) and transferred to an S-VHS 
video system for subsequent offline analysis. For analysis of 
apoptotic cell death, in vivo staining of myocyte nuclei was 
achieved by intravenous injection of bisbenzimide (10 µmol/
kg bw; Hoechst 33342, Sigma).
Microcirculatory Analysis. For quantitative offline analy-
sis, a computer-assisted microcirculation image analysis sys-
tem was used (CapImage v7.4, Zeintl, Heidelberg, Germany). 
As previously described (9, 13, 14), functional capillary den-
sity was defined as the total length of red blood cell–perfused 
capillaries per observation area and given in cm/cm2. With use 
of densitometric techniques, macromolecular leakage was as-
sessed in several fields per image and expressed as the ratio 
of fluorescence intensity selected from the perivascular area 
to the corresponding intravascular area (plasma gaps in the 
microvessels between erythrocytes [15]). For assessment of 
leukocyte-endothelial cell interaction in postcapillary venules, 
flow behavior of leukocytes was analyzed with respect to free 
floating, rolling, and adherent leukocytes. Rolling leukocytes 
were defined as those cells moving along the vessel wall at a 
velocity less than 40% of that of leukocytes at the centerline 
and were expressed as a percentage of the total leukocyte flux. 
Venular leukocyte adherence was defined as the number of leu-
kocytes not moving or detaching from the endothelial lining 
of the venular vessel wall during an observation period of 20 s. 
Assuming cylindrical microvessel geometry, leukocyte adher-
ence was expressed as nonmoving cells per endothelial surface 
(n/mm2), calculated from the diameter and length of the ves-
sel segment analyzed. In postcapillary venules, centerline red 
blood cell velocity was determined using the line shift method 
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(CapImage, Dr. Zeintl Software, Heidelberg, Germany). To 
minimize bias in selection of venules with respect to the lo-
cal leukocyte-endothelial cell interaction, postcapillary venules 
were chosen during visualization in blue light epi-illumina-
tion, which does not allow visualizing leukocyte flow behavior. 
Thereafter, filter set was changed to green light epi-illumination 
for assessment of inflammatory leukocyte response. Reduced 
nicotinamide adenine dinucleotide (NADH) fluorescence 
of skeletal muscle tissue was densitometrically assessed after 
2 s of ultraviolet epi-illumination by computer-assisted gray 
level determination (16). To avoid interference of gray levels 
with microvascular structures, analysis was strictly limited to 
the intercapillary space. Within ten observation fields of skel-
etal muscle, apoptotic cell death was assessed by counting the 
number of bisbenzimide-stained cells that showed apoptosis-
associated condensation, fragmentation, and crescent-shaped 
formation of their nuclear chromatin (17, 18).
Laboratory Analysis
Arterial blood samples were withdrawn for analysis of blood 
gases (Rapidlab 348, Bayer Vital, Fernwald, Germany) and blood 
cell count using a Coulter counter (AcTdiff, Coulter, Hamburg, 
Germany).
Histology and Immunohistochemistry. At the end of each 
experiment, EDL muscle tissue was fixed in 4% phosphate-
buffered formalin for 2–3 days and then embedded in paraffin. 
From the paraffin-embedded tissue blocks, 4-μm sections were 
cut and exposed to an apoptosis-specific staining kit (indirect in 
situ DNA nick-end labeling [terminal deoxynucleotidyl transfer-
ase dUTP nick-end labeling, TUNEL] assay, ApopTag; Chemicon 
International Inc., Temecula, CA) according to the manufac-
turer’s instructions. Quantitative analysis was performed by 
counting the number of TUNEL positive tissue–confined cells 
in 50 consecutive high-power fields (HPF; ×400 magnifica-
tion). For quantitative assessment of leukocyte tissue infiltra-
tion, tissue specimens were stained by the AS-D chloroacetate 
esterase technique. Leukocytes were identified by positive 
staining and morphology in 50 HPF in a blinded fashion using 
a light microscopy (×40 objective) and recorded by the num-
ber of cells/HPF.
Statistical Analysis. Results were given as mean ± sem. 
After proving the assumption of normality (Kolmogorov-
Smirnov), comparisons between the experimental groups 
were performed by a univariate analysis of variance, followed 
by the Bonferroni post hoc multiple comparison proce-
dure (SigmaStat, Jandel, San Rafael, CA). To assess the cor-
relation between different microcirculatory parameters, lin-
ear regression analysis was used. Statistical significance was 
set at p < 0.05.
RESULTS
Systemic Hemodynamics
Animals that underwent local soft-tissue trauma and endotox-
emia revealed increased heart rate and pronounced thrombocy-
topenia when compared with non-lipopolysaccharide-exposed 
and sham-operated animals. No changes were observed for 
hemoglobin, leukocyte count, electrolytes, and blood clotting 
parameters (Table 1).







 Mean arterial blood  
pressure (mm Hg)
109 ± 7 111 ± 10 111 ± 7 107 ± 4 99 ± 7
 Heart rate (beats/min) 364 ± 8 377 ± 17 420 ± 11a 382 ± 17 417 ± 8a
Blood parameters
 Hemoglobin (mmol/L) 8.8 ± 0.3 8.3 ± 0.2 8.6 ± 0.2 8.0 ± 0.3 8.4 ± 0.1
 Hematocrit (%) 43 ± 4 42 ± 1 42 ± 1 41 ± 4 40 ± 1
 Thrombocytes (109/L) 752 ± 61 776 ± 70 160 ± 66a–c 694 ± 118 157 ± 53a–c
 Leukocytes (109/L) 8.5 ± 0.7 8.3 ± 0.9 11.1 ± 2.2 11.4 ± 1.8 10.3 ± 1.3
 Na+ (mmol/L) 139 ± 3 139 ± 1 140 ± 1 140 ± 1 139 ± 1
 K+ (mmol/L) 3.9 ± 0.4 3.9 ± 0.1 4.0 ± 0.3 4.1 ± 0.1 3.8 ± 1.6
 Thromboplastin time (%) 149 ± 1 141 ± 5 135 ± 6 135 ± 1 135 ± 0
 Partial thromboplastin time (s) 26.0 ± 3.4 22.3 ± 0.9 30.2 ± 3.7 29.4 ± 1.3 29.4 ± 1.3
Values are given as mean ± sem. Blood samples were withdrawn at 24 h after soft-tissue trauma.
ap < 0.05 vs. sham.
bp < 0.05 vs. trauma.
cp < 0.05 vs. therapy.
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Microvascular Perfusion
Closed soft-tissue trauma and trauma with subsequent en-
dotoxemia caused a tremendous impairment of functional 
capillary density with values less than 400 cm/cm2. Treatment 
with antithrombin restored nutritive capillary perfusion in en-
dotoxemic animals (therapy/lipopolysaccharide: 469 ± 22 cm/
cm2) and nonendotoxemic animals (therapy: 438 ± 29 cm/cm2), 
however, not reaching physiologic baseline values (Fig. 1A). 
In line with nutritive perfusion failure, significantly increased 
NADH autofluorescence of skeletal muscle tissue was observed 
after closed soft-tissue injury (trauma: 80 ± 2 aU) and after sub-
sequent endotoxemia (trauma/lipopolysaccharide: 77 ± 4 aU), 
indicating pronounced tissue hypoxia. In contrast, animals 
treated with antithrombin exhibited significant reduction 
of tissue NADH (therapy: 57 ± 3 aU; therapy/lipopolysac-
charide: 61 ± 5 aU), further underlining the concomitant 
improvement of capillary perfusion (Fig. 1B). Regression 
analysis revealed a significant inverse correlation between 
functional capillary density and NADH autofluorescence 
of skeletal muscle tissue with a regression coefficient of 
r = –0.51 (p < 0.05). Macromolecular leakage increased upon 
trauma and endotoxemia. Therapeutic intervention with an-
tithrombin was accompanied by a significantly reduced mac-
romolecular leakage, as found in nontraumatized animals 
(Fig. 2). Capillary diameters and red blood cell velocity did 
not significantly differ among the groups, indicating compa-
rable microhemodynamic conditions.
Inflammatory Cell Response
Soft-tissue trauma alone as well as in combination with endo-
toxemia provoked a marked inflammatory cell response with 
leukocytes rolling along and firmly attaching (Table 2) to the 
venular endothelium. Antithrombin effectively limited the 
inflammatory response with reduced numbers of leukocytes 
interacting with the postcapillary venular endothelium after 
both trauma and trauma with the subsequent endotoxic hit 
(Table 2). In line with in vivo fluorescence microscopic analysis 
of leukocyte-endothelial cell interaction, histology of trauma-
tized muscle tissue revealed an inflammatory cell infiltration, 
Figure 1. Functional capillary density (A) and nicotinamide adenine 
dinucleo tide (NADH) autofluorescence (b) of skeletal muscle tissue at 
24 hrs after soft-tissue trauma and subsequent exposure to lipopolysac-
charide (LPS). Animals were treated either with antithrombin (therapy; 
therapy/LPS) or vehicle solution (trauma; trauma/LPS). Sham-operated 
animals without trauma and endotoxemia (sham) served as controls. 
Values are given as mean ± sem. *p < 0.05 vs. sham; #p < 0.05 vs. trauma, 
+p < 0.05 vs. trauma/LPS.
Figure 2 . Macromolecular leakage of fluorescein isothiocyanate dextran 
(ratio) within skeletal muscle tissue at 24 hrs after soft-tissue trauma 
and subsequent exposure to lipopolysaccharide (LPS). Animals were 
treated either with antithrombin (therapy; therapy/LPS) or vehicle solution 
(trauma; trauma/LPS). Sham-operated animals without trauma and endo-
toxemia (sham) served as controls. Values are given as mean ± sem;  
*p < 0.05 vs. sham; #p < 0.05 vs. trauma, and +p < 0.05 vs. trauma/LPS.
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which was reduced in antithrombin-treated animals (data not 
shown).
Tissue Cell Death
Upon trauma, nontreated animals revealed enhanced numbers 
of apoptotic muscle cell nuclei, both in vivo and by indirect in 
situ DNA nick-end labeling (TUNEL) assay. Treatment with an-
tithrombin reduced apoptotic cell death in both methods (Fig. 
3A and B).
DISCUSSION
In this study, we could show that antithrombin prevents leu-
kocyte adherence, microvascular perfusion failure, and micro-
vascular leakage in traumatized skeletal muscle tissue under 
conditions of systemic endotoxemia. With respect to the fact 
that the severity of soft-tissue trauma is a critical prognostic 
factor for morbidity and mortality following complex injuries 
of the extremities (13), the findings allow one to conclude that 
treatment with antithrombin might reduce secondary tissue 
damage.
Antithrombin III has been shown to reduce mortality rate 
and to prevent organ dysfunction in different animal models 
(19, 20). Furthermore, antithrombin was capable in delay-
ing microvascular thrombus formation in a murine model 
(21, 22). Beside its anticoagulatory actions, antithrombin re-
veals anti-inflammatory activities in a variety of experimental 
models, which are independent of its direct influence on the 
coagulatory cascade (7, 23). Beneficial effects of antithrombin 
could also be shown in patients with severe sepsis (24), which, 
however, have not been confirmed in the multinational Kyber-
Sept trial (25). Despite the fact that antithrombin application 
is currently not recommended as an adjunctive therapy by the 
surviving sepsis campaign guidelines (26), there is evidence for 
antithrombin to effectively reduce mortality rate in a subgroup 
of septic patients not receiving heparin (27). To our knowl-
edge, the benefit of antithrombin application on traumatized 
skeletal muscle tissue in an experimental set-up comparable to 
the present one has not been investigated yet.
The animal model used in this study was formerly described 
by our group and allows the intravital fluorescence microscopy 
of traumatized skeletal muscle for quantitative analysis of mi-
crovascular perfusion and inflammatory cell interaction under 
endotoxemic conditions (9, 28). Soft-tissue trauma alone leads 
to an increase in leukocyte-endothelial cell interaction and a 
marked reduction in capillary perfusion. In line with nutritive 
perfusion failure, high-NADH autofluorescence was observed, 
indicating local tissue hypoxia (25). In general, interruption of 
oxidative phosphorylation caused by inadequate oxygen supply 
is reflected by an increase of NADH levels (29). Thus, in vivo 
NADH-fluorescence microscopy allows noninvasive investiga-
tion of organ metabolism as a result of alterations in oxidative 
phosphorylation (17). In line with this, we could demonstrate 
a strong negative regression between NADH autofluorescence 
and microvascular perfusion within the traumatized skeletal 
muscle tissue. Microcirculatory disorders were even more pro-
nounced by the additional lipopolysaccharide challenge 6 hrs 
after trauma induction, representing an endotoxemic second 
hit, which probably leads to thrombotic occlusion of microves-
sels secondary to the perfusion failure caused by capillary mi-
crodamage by the soft-tissue trauma itself. Treatment with 
antithrombin was capable in modulating these trauma- and 
endotoxemia-induced microvascular sequelae.
It is known that the glycocalyx, a layer of glucosamino-
glycans on the endothelial surface, is impaired in sepsis, thus 
enabling interaction of white blood cells and platelets with 
the endothelial surface (30, 31). Massive leukocyte rolling 
and adherence to the endothelial surface in both endotoxemic 
animals and animals with isolated soft-tissue trauma could 
be demonstrated. Furthermore, we observed a significant de-
crease in platelet counts in endotoxemic animals, indicating 
a septic consumption coagulopathy caused by increased in-
teraction of platelets with the endothelial surface (30). These 
consumed thrombocytes cannot be restored by antithrom-
bin but have to be reproduced, which takes longer than the 
observation time is. Thrombocytopenia was not induced by 
soft-tissue trauma alone. This issue might be due to the fact 
that trauma alone leads to a circumscribed endothelial dam-
age with only local increase of cell-cell interaction, in contrast 
to a systemic impairment of the endothelial surface in sepsis.
Antithrombin was highly effective in preventing leukocyte 
adherence to the venular endothelium. Antithrombin-treated 
animals revealed values of leukocyte adherence comparable to 
those in sham controls. The mechanism of action remains con-
troversial. While some authors credit the effect of antithrombin 
on leukocyte-endothelial cell interaction with its anticoagulant 
activity as the primary mechanism of action (32), others assume 
the mechanism being independent on the coagulatory pathway 
(8, 30). Further studies are needed to fully characterize the 






Leukocyte rolling (%) 30 ± 2 41 ± 5 48 ± 3a 43 ± 2 48 ± 3a
Leukocyte adherence (n/mm2) 204 ± 20 686 ± 37a 773 ± 35a 176 ± 38b,c 237 ± 20b,c
Values are given as mean ± sem. Blood samples were withdrawn at 24 h after soft-tissue trauma.
ap < 0.05 vs. sham.
bp < 0.05 vs. trauma.
cp < 0.05 vs. trauma/lipopolysaccharides.
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mechanisms   of   antithrombin-mediated  protection   in traumatized 
patients with sepsis.
In summary, the protective effect of antithrombin on trau-
matized skeletal muscle tissue implies that antithrombin reveals 
potent anti-inflammatory properties to prevent skeletal muscle 
from secondary tissue damage in order to hasten healing and 
to improve performance following closed soft-tissue injury. 
Furthermore, we observed effective amelioration of tissue per-
fusion and thus adequate tissue oxygen supply. Despite its well- 
known anticoagulatory properties, we did not observe adverse 
side effects, like bleeding complications in traumatized tissue. 
Our investigation shows that the anticoagulant pathway of 
antithrombin may represent one key mechanism in preventing 
traumatized muscle tissue from microvascular dysfunction in 
a double-hit model.
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